CA
Cormorant Asset Management, LP
BOSTON MA · SEC CIK 0001583977
$1.95B2026Q2 reported value
50Positions
59.2%Top 10 weight · largest 11.0%
7 / 9New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
CLYM New+$27.46M
SYRE New+$19.98M
DFTX New+$18.82M
BHVN Added+$12.65M
ANL Added+$12.42M
2026Q2 top sells estimated at quarter-end value
PRAX Reduced-$82.19M
CENTESSA PHARMAC Sold out-$41.71M
MBX Reduced-$31.46M
EWTX Reduced-$30.47M
MLTX Reduced-$24.82M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| PRAX | PRAXIS PRECISION MEDICINES I | $214.27M | 10.98% | 640,000 | -245,500 | -27.7% | -$82.19M | Reduced |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | $136.23M | 6.98% | 17,878,594 | 0 | 0.0% | — | Unchanged |
| PBLS | PARABILIS MEDICINES INC | $126.33M | 6.47% | 4,615,612 | 4,615,612 | — | — | First reported |
| RAPP | RAPPORT THERAPEUTICS INC | $110.74M | 5.67% | 2,657,521 | -300,000 | -10.1% | -$12.50M | Reduced |
| ERAS | ERASCA INC | $109.92M | 5.63% | 6,000,000 | 200,000 | 3.4% | $3.66M | Added |
| EWTX | EDGEWISE THERAPEUTICS INC | $101.98M | 5.23% | 2,510,000 | -750,000 | -23.0% | -$30.47M | Reduced |
| EYPT | EYEPOINT INC | $100.10M | 5.13% | 7,000,000 | -1,265,000 | -15.3% | -$18.09M | Reduced |
| ALMS | ALUMIS INC | $92.46M | 4.74% | 3,285,596 | -663,645 | -16.8% | -$18.67M | Reduced |
| ABVX | ABIVAX SA | $89.95M | 4.61% | 675,000 | -85,000 | -11.2% | -$11.33M | Reduced |
| DNTH | DIANTHUS THERAPEUTICS INC | $73.11M | 3.75% | 750,000 | -200,000 | -21.1% | -$19.50M | Reduced |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | $63.18M | 3.24% | 900,000 | -159,331 | -15.0% | -$11.19M | Reduced |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $62.41M | 3.20% | 3,205,433 | -1,275,000 | -28.5% | -$24.82M | Reduced |
| BIOA | BIOAGE LABS INC | $58.59M | 3.00% | 2,390,605 | -500,000 | -17.3% | -$12.26M | Reduced |
| ORKA | ORUKA THERAPEUTICS INC | $50.76M | 2.60% | 533,340 | 0 | 0.0% | — | Unchanged |
| ANL | ADLAI NORTYE LTD | $45.75M | 2.34% | 3,978,229 | 1,080,372 | 37.3% | $12.42M | Added |
| BBIO | BRIDGEBIO PHARMA INC | $40.96M | 2.10% | 550,000 | -300,000 | -35.3% | -$22.34M | Reduced |
| TNGX | TANGO THERAPEUTICS INC | $40.64M | 2.08% | 1,300,000 | -125,000 | -8.8% | -$3.91M | Reduced |
| BHVN | BIOHAVEN LTD | $38.84M | 1.99% | 2,610,000 | 850,000 | 48.3% | $12.65M | Added |
| AGMB | AGOMAB THERAPEUTICS NV | $32.00M | 1.64% | 2,465,348 | 0 | 0.0% | — | Unchanged |
| MBX | MBX BIOSCIENCES INC | $30.36M | 1.56% | 550,000 | -570,000 | -50.9% | -$31.46M | Reduced |
| CLYM | CLIMB BIO INC | $27.46M | 1.41% | 2,106,000 | 2,106,000 | — | $27.46M | New |
| OLMA | OLEMA PHARMACEUTICALS INC | $26.90M | 1.38% | 2,150,000 | -1,750,000 | -44.9% | -$21.89M | Reduced |
| DMRA | DAMORA THERAPEUTICS INC | $26.01M | 1.33% | 1,000,000 | -525,000 | -34.4% | -$13.66M | Reduced |
| PHVS | PHARVARIS N V | $25.93M | 1.33% | 750,000 | -250,000 | -25.0% | -$8.64M | Reduced |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | $22.00M | 1.13% | 2,344,971 | 0 | 0.0% | — | Unchanged |
| SYRE | SPYRE THERAPEUTICS INC | $19.98M | 1.02% | 225,000 | 225,000 | — | $19.98M | New |
| DFTX | DEFINIUM THERAPEUTICS INC | $18.82M | 0.96% | 400,000 | 400,000 | — | $18.82M | New |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | $16.95M | 0.87% | 500,000 | -450,000 | -47.4% | -$15.25M | Reduced |
| ROIV | ROIVANT SCIENCES LTD | $16.81M | 0.86% | 475,000 | -275,000 | -36.7% | -$9.73M | Reduced |
| CABA | CABALETTA BIO INC | $15.55M | 0.80% | 5,000,000 | -500,000 | -9.1% | -$1.55M | Reduced |
| HLXC | HELIX ACQUISITION CORP III | $13.81M | 0.71% | 1,297,500 | 0 | 0.0% | — | Unchanged |
| ASND | ASCENDIS PHARMA A/S | $13.34M | 0.68% | 50,000 | -45,000 | -47.4% | -$12.00M | Reduced |
| KLRA | KAILERA THERAPEUTICS INC | $12.12M | 0.62% | 550,000 | 550,000 | — | — | First reported |
| INSM | INSMED INC | $8.00M | 0.41% | 75,000 | -115,000 | -60.5% | -$12.26M | Reduced |
| FTH | FAETH THERAPEUTICS INC | $7.66M | 0.39% | 1,028,242 | 722,020 | 235.8% | $5.38M | Added |
| ELVN | ENLIVEN THERAPEUTICS INC | $7.61M | 0.39% | 150,000 | 150,000 | — | $7.61M | New |
| TARS | TARSUS PHARMACEUTICALS INC | $6.29M | 0.32% | 100,000 | -125,000 | -55.6% | -$7.87M | Reduced |
| — | IBIO INC | $6.25M | 0.32% | 3,570,000 | 3,570,000 | — | $6.25M | New |
| — | CRINETICS PHARMACEUTICALS IN | $4.68M | 0.24% | 125,000 | -125,000 | -50.0% | -$4.68M | Reduced |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $4.59M | 0.24% | 175,000 | -275,000 | -61.1% | -$7.21M | Reduced |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | $4.08M | 0.21% | 50,000 | -50,000 | -50.0% | -$4.08M | Reduced |
| GPCR | STRUCTURE THERAPEUTICS INC | $4.03M | 0.21% | 75,000 | -100,000 | -57.1% | -$5.37M | Reduced |
| — | RESEARCH ALLIANCE CORP III | $3.96M | 0.20% | 370,000 | 370,000 | — | — | First reported |
| COGT | COGENT BIOSCIENCES INC | $3.87M | 0.20% | 100,000 | -100,000 | -50.0% | -$3.87M | Reduced |
| ALT | ALTIMMUNE INC | $3.80M | 0.19% | 1,250,000 | 1,250,000 | — | $3.80M | New |
| AMLX | AMYLYX PHARMACEUTICALS INC | $3.59M | 0.18% | 200,000 | -150,000 | -42.9% | -$2.69M | Reduced |
| ODTX | ODYSSEY THERAPEUTICS INC | $3.27M | 0.17% | 175,000 | 175,000 | — | — | First reported |
| PCVX | VAXCYTE INC | $2.91M | 0.15% | 50,000 | -50,000 | -50.0% | -$2.91M | Reduced |
| — | BOUNDLESS BIO INC | $2.50M | 0.13% | 1,000,000 | 1,000,000 | — | $2.50M | New |
| — | QUINCE THERAPEUTICS INC | $100,009 | 0.01% | 5,498 | 5,498 | — | — | First reported |
| — | CENTESSA PHARMACEUTICALS PLC | $0 | 0.00% | 0 | -1,050,000 | -100.0% | -$41.71M | Sold out |
| MAZE | MAZE THERAPEUTICS INC | $0 | 0.00% | 0 | -750,000 | -100.0% | -$22.39M | Sold out |
| — | TERNS PHARMACEUTICALS INC | $0 | 0.00% | 0 | -300,000 | -100.0% | -$15.82M | Sold out |
| ZURA | ZURA BIO LTD | $0 | 0.00% | 0 | -1,450,000 | -100.0% | -$8.63M | Sold out |
| AXSM | AXSOME THERAPEUTICS INC. | $0 | 0.00% | 0 | -50,000 | -100.0% | -$8.45M | Sold out |
| OLMA | OLEMA PHARMACEUTICALS INC Call | $0 | 0.00% | 0 | -500,000 | -100.0% | -$7.46M | Sold out |
| GLUE | MONTE ROSA THERAPEUTICS INC | $0 | 0.00% | 0 | -400,000 | -100.0% | -$6.58M | Sold out |
| RLYB | RALLYBIO CORP | $0 | 0.00% | 0 | -400,000 | -100.0% | -$3.59M | Sold out |
| — | CONTEXT THERAPEUTICS INC | $0 | 0.00% | 0 | -529,550 | -100.0% | -$1.39M | Sold out |